ArticleEuropean journal of medical research2023

Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.

Dandan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.